ES2108572T3 - Procedimiento para el aislamiento de acido clavulanico y de sales farmaceuticamente aceptables de este a partir del caldo de fermentacion de streptomyces sp p 6621 ferm p 2804. - Google Patents
Procedimiento para el aislamiento de acido clavulanico y de sales farmaceuticamente aceptables de este a partir del caldo de fermentacion de streptomyces sp p 6621 ferm p 2804.Info
- Publication number
- ES2108572T3 ES2108572T3 ES95909194T ES95909194T ES2108572T3 ES 2108572 T3 ES2108572 T3 ES 2108572T3 ES 95909194 T ES95909194 T ES 95909194T ES 95909194 T ES95909194 T ES 95909194T ES 2108572 T3 ES2108572 T3 ES 2108572T3
- Authority
- ES
- Spain
- Prior art keywords
- clavulanic acid
- isolation
- pharmaceutically acceptable
- acceptable salts
- fermentation broth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/02—Separating microorganisms from their culture media
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Seasonings (AREA)
Abstract
SE HA DESCUBIERTO UN PROCESO NUEVO Y MEJORADO PARA EL AISLAMIENTO DE ACIDO CLAVULANICO Y SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO COMO CLAVULANATO POTASICO A PARTIR DEL CALDO DE CULTIVO DE FERMENTACION ACUOSA DE ESTREPTOMICES SP P 6621 FERM P 2804, EN DONDE A PARTIR DEL CALDO DE CULTIVO DE FERMENTACION ACUOSA EL MICELIUM, UNA MAYOR PARTE DE LAS PROTEINAS Y DE OTRAS PARTICULAS SOLIDAS SUSPENDIDAS SON ELIMINADAS POR MICROFILTRACION EN UN VALOR DE PH DEL MEDIO ENTRE 5.8 Y 6.2 Y A UNA TEMPERATURA ENTRE APROX. 20 ADO (LA FASE ACUOSA) ES OPCIONAL Y ADICIONALMENTE PURIFICADO POR ULTRAFILTRACION, Y EL CALDO DE CULTIVO PURIFICADO DE ESTA MANERA ES CONCENTRADO POR OSMOSIS INVERSA, DESPUES ES DIRECTAMENTE EXTRAIDO EN UNA CONTRACORRIENTE EN EXTRACTORES CENTRIFUGOS CON UN DISOLVENTE ORGANICO INMISCIBLE EN AGUA EN UN VALOR DE PH DEL MEDIO ENTRE 1 Y 3, CON LO CUAL LAS PROTEINAS TODAVIA RESTANTES SON ELIMINADAS SIMULTANEAMENTE, DE LA FASE ORGANICA OBTENIDA LAS IMPUREZAS SOLUBLES EN AGUA SON ELIMINADASLAVANDO LA FASE ORGANICA CON AGUA, LA FASE ORGANICA ES SECADA IN VACUO EN UNA COLUMNA DE RECTIFICACION PARA UN CONTENIDO EN AGUA INFERIOR A UN 0.1 % VOL. Y DESPUES CONCENTRADA POR EVAPORACION, DESCOLORADA POR UN TRATAMIENTO CON CARBONO ACTIVO, Y DESPUES EL ACIDO CLAVULANICO PRESENTE EN LA FASE ORGANICA SECA, MAS CORRECTAMENTE EN LA FASE DE ACETATO DE ETILO, ES AISLADO Y PURIFICADO POR UNA REACCION CON N,N''-DIISOPROPILETILENDIAMINA A UNA TEMPERATURA DE APROX. TEMPERATURA AMBIENTE PARA EL INTERMEDIARIO DICLAVULANATO DE N,N''DIISOPROPILETILENODIAMONICO QUE ES AISLADO Y DESPUES REACCIONANDO CON HEXANOATO 2-ETILO POTASICO EN ISOPROPANOL PARA PRODUCIR LA SAL POTASICA DEL ACIDO CLAVULANICO QUE TENGA ALTA PUREZA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9400107A SI9400107A (en) | 1994-03-02 | 1994-03-02 | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2108572T3 true ES2108572T3 (es) | 1997-12-16 |
Family
ID=20431337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95909194T Expired - Lifetime ES2108572T3 (es) | 1994-03-02 | 1995-02-23 | Procedimiento para el aislamiento de acido clavulanico y de sales farmaceuticamente aceptables de este a partir del caldo de fermentacion de streptomyces sp p 6621 ferm p 2804. |
Country Status (25)
Country | Link |
---|---|
US (4) | US5780274A (es) |
EP (1) | EP0748387B1 (es) |
JP (1) | JP2948661B2 (es) |
KR (1) | KR100293172B1 (es) |
CN (1) | CN1055694C (es) |
AT (1) | ATE159549T1 (es) |
AU (1) | AU694176B2 (es) |
BG (1) | BG62213B1 (es) |
CA (1) | CA2184619A1 (es) |
CZ (1) | CZ284117B6 (es) |
DE (1) | DE69500925T2 (es) |
DK (1) | DK0748387T3 (es) |
ES (1) | ES2108572T3 (es) |
FI (1) | FI963408A (es) |
GR (1) | GR3025942T3 (es) |
HU (1) | HUT74944A (es) |
NO (1) | NO318374B1 (es) |
NZ (1) | NZ279958A (es) |
PL (1) | PL180520B1 (es) |
RO (1) | RO118760B1 (es) |
RU (1) | RU2206613C2 (es) |
SI (1) | SI9400107A (es) |
SK (1) | SK279780B6 (es) |
WO (1) | WO1995023870A1 (es) |
ZA (1) | ZA951689B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT400033B (de) | 1992-03-10 | 1995-09-25 | Biochemie Gmbh | Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben |
SI9400107A (en) * | 1994-03-02 | 1995-10-31 | Lek Tovarna Farmacevtskih | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
GB9500977D0 (en) | 1995-01-19 | 1995-03-08 | Smithkline Beecham Plc | Novel process |
SI9500074A (en) † | 1995-03-10 | 1996-10-31 | Lek Tovarna Farmacevtskih | Process for preparation of alkani salts of clavulanic acid. |
SI9500134B (sl) * | 1995-04-20 | 2004-04-30 | Lek, | Postopek za pripravo čistih alkalijskih soli klavulanske kisline |
GB9515809D0 (en) * | 1995-08-02 | 1995-10-04 | Smithkline Beecham Plc | Process |
SI9500265A1 (en) | 1995-08-28 | 1997-02-28 | Lek Tovarna Farmacevtskih | Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration |
AT403375B (de) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | Verfahren zur fällung von alkalisalzen der clavulansäure |
US6414142B1 (en) * | 1996-06-13 | 2002-07-02 | Smithkline Beecham Corporation | Process for preparing potassium clavulanate |
AU5551698A (en) * | 1996-11-11 | 1998-06-03 | Gist-Brocades B.V. | Process for the preparation of salts and esters of clavulanic acid |
AT404728B (de) * | 1996-11-27 | 1999-02-25 | Biochemie Gmbh | Verfahren zur herstellung von clavulansäure-aminsalzen |
WO1998042858A1 (en) * | 1997-03-24 | 1998-10-01 | Cipan-Companhia Industrial Produtora De Antibióticos, S.A. | Process for the isolation of a pharmaceutically acceptable alkali metal salt of clavulanic acid |
DE69700903T2 (de) | 1997-03-24 | 2000-07-06 | Cipan Comp Ind Prod | Verfahren zur Isolierung eines pharmazeutisch verträglichen Alkalimetallsalzes der Clavulansäure |
DZ2456A1 (fr) * | 1997-04-04 | 2003-01-18 | Smithkline Beecham Plc | Procédé de préparation de sels de l'acide clavulanique. |
US6979735B1 (en) * | 1999-04-01 | 2005-12-27 | Dsm N.V. | Agglomerates by crystallization |
KR100827898B1 (ko) | 2000-05-13 | 2008-05-07 | 스미스클라인비이참피이엘시이 | 클라불란산의 염의 정제 방법 |
GB0022841D0 (en) * | 2000-09-18 | 2000-11-01 | Smithkline Beecham Plc | Process |
KR100443082B1 (ko) * | 2002-10-18 | 2004-08-04 | 삼성전자주식회사 | 반도체 장치의 트랜지스터 제조 방법 |
KR100768476B1 (ko) | 2005-11-24 | 2007-10-18 | 한국해양연구원 | 항암물질을 생산하는 방선균 스트렙토마이세스 속 균주,이의 분리방법, 이로부터 반고형 추출물을 제조하는 방법,이로부터 유래한 반고형 추출물 및 이를 이용한 항암제조성물 |
CN102838624B (zh) * | 2012-09-07 | 2014-10-29 | 安徽普朗膜技术有限公司 | 一种从发酵液中纯化克拉维酸的方法 |
CN104910194A (zh) * | 2015-05-28 | 2015-09-16 | 高希章 | 一种克拉维酸钾的制备方法及其复方制剂 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3873425A (en) * | 1971-11-19 | 1975-03-25 | Tatsuyoshi Kobayashi | Process for producing itaconic acid |
GB1508977A (en) * | 1974-04-20 | 1978-04-26 | Beecham Group Ltd | Beta-lactam antibiotic from streptomyces clavuligerus |
US4110165A (en) | 1974-04-20 | 1978-08-29 | Beecham Group Limited | Process for the production of clavulanic acid |
NZ177159A (en) * | 1974-04-20 | 1978-03-06 | Beecham Group Ltd | Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions |
US4140764A (en) * | 1974-12-18 | 1979-02-20 | Beecham Group Limited | β-Lactamase inhibitors and process for their preparation |
US4144242A (en) | 1975-02-07 | 1979-03-13 | Glaxo Laboratories Limited | Process for the purification of clavulanic acid |
US4148880A (en) * | 1975-08-13 | 1979-04-10 | Pfizer Inc. | Mixture of antibiotics produced by a species of actinoplanes |
GB1563103A (en) | 1975-10-13 | 1980-03-19 | Beecham Group Ltd | Process for the preparation of clavulanic acid |
GB1578739A (en) * | 1976-07-23 | 1980-11-05 | Beecham Group Ltd | Amine salts of clavulanic acid methods for their preparation and compositions containing them |
JPS55162993A (en) * | 1979-06-07 | 1980-12-18 | Sanraku Inc | Preparation of culavulanic acid |
US4454069A (en) | 1979-08-24 | 1984-06-12 | Beecham Group Limited | Clavulanic acid salts and their preparation from the tertiary butyl amine salt |
DE2948607A1 (de) | 1979-12-03 | 1981-06-11 | Chemische Fabrik Dr. Meyer-Castens & Co Nfg., 2000 Hamburg | Verfahren zur herstellung eines emulgators auf lecithinbasis |
JPS5791196A (en) | 1980-11-27 | 1982-06-07 | Takeda Chem Ind Ltd | Separation of inosine, guanosine or their mixture from cell bodies and high polymeric substances |
DE3146190A1 (de) | 1981-11-21 | 1983-06-16 | Hoechst Ag, 6230 Frankfurt | Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen |
JPS6070092A (ja) * | 1983-09-26 | 1985-04-20 | Ajinomoto Co Inc | グルタミン酸発酵液からのグルタミン酸結晶の取得法 |
US4911847A (en) | 1983-12-20 | 1990-03-27 | Membrex, Inc. | Process for controlling the permeate composition in a rotary filtration device |
NZ213963A (en) | 1984-10-27 | 1989-01-06 | Antibioticos Sa | Production of clavulanic acid |
GB8521516D0 (en) | 1985-08-29 | 1985-10-02 | Beecham Group Plc | Compounds |
IT1221982B (it) * | 1987-07-08 | 1990-08-31 | Mini Ricerca Scient Tecnolog | Antibiotici ab 006 e processo per la loro produzione |
DE3730868A1 (de) * | 1987-09-15 | 1989-03-23 | Henkel Kgaa | Verfahren zur abtrennung von biotechnisch hergestellten wertstoffen aus einer fermenterbruehe durch querstrom-mikro- und/oder ultrafiltration |
GB8823706D0 (en) * | 1988-10-10 | 1988-11-16 | Alcan Int Ltd | Microfilter device |
ES2010144A6 (es) * | 1989-03-01 | 1989-10-16 | Pharma Mar S A Pharmar | Un procedimiento de floculacion-coagulacion de caldos de fermentacion de streptomyces sp. que permite la obtencion directa de liquidos completamente transparentes. |
ES2010143A6 (es) * | 1989-03-01 | 1989-10-16 | Pharma Mar S A Pharmar | Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp. |
US5024937A (en) | 1989-04-06 | 1991-06-18 | Dow Corning Corporation | Method for processing aqueous fermentation broths |
EP0431679B1 (en) * | 1989-12-05 | 1994-10-19 | Merck & Co. Inc. | Method of stabilizing recombinant hepatitis B virus surface proteins from yeast |
DE4005132A1 (de) | 1990-02-17 | 1991-08-22 | Akzo Gmbh | Verfahren zum herstellen von hohlfadenstapeln |
US5240600A (en) | 1990-07-03 | 1993-08-31 | International Environmental Systems, Inc., Usa | Water and wastewater treatment system |
JP3021562B2 (ja) * | 1990-07-16 | 2000-03-15 | ダイセル化学工業株式会社 | ナイシンの製造方法 |
US5073263A (en) | 1990-09-21 | 1991-12-17 | Fagundes Carlos A | Method and article for restraining extrusion of feed spacers and circumferential expansion in spiral filtration modules |
US5268283A (en) * | 1990-10-05 | 1993-12-07 | Miles Inc. | Method for the production of detergent builder formulations utilizing spray granulated citric acid and salts thereof |
DE4031854A1 (de) * | 1990-10-08 | 1992-04-09 | Basf Ag | Mikroorganismus und verfahren zur gewinnung von anthranilsaeure |
JP2615272B2 (ja) * | 1991-03-22 | 1997-05-28 | 日本碍子株式会社 | 蛋白質溶液中の蛋白有価物の回収方法 |
US5470356A (en) | 1991-10-11 | 1995-11-28 | Meszaros; Laszlo A. | Sulfur dye compositions and their production |
AT399155B (de) * | 1992-03-26 | 1995-03-27 | Lek Tovarna Farmacevtskih | Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung |
SI9300296B (sl) * | 1992-06-11 | 1998-06-30 | Smithkline Beecham P.L.C. | Postopek in intermedianti za pripravo klavulanske kisline |
GB9222841D0 (en) | 1992-10-31 | 1992-12-16 | Smithkline Beecham Plc | Novel process |
SI9200139A (en) * | 1992-07-08 | 1994-03-31 | Lek Tovarna Farmacevtskih | New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them |
KR100200239B1 (ko) * | 1992-10-21 | 1999-06-15 | 김충환 | 클라불란산 칼륨염의 제조방법 |
EP1262564A3 (en) | 1993-01-07 | 2004-03-31 | Sequenom, Inc. | Dna sequencing by mass spectrometry |
GB9305565D0 (en) | 1993-03-18 | 1993-05-05 | Smithkline Beecham Plc | Novel compounds and processes |
US5741903A (en) | 1993-03-26 | 1998-04-21 | Gist-Brocades N.V. | Diamine salts for purification of clavulanic acid |
CA2135671A1 (en) * | 1993-03-26 | 1994-10-13 | Pieter G. Weber | Diamine salts of clavulanic acid |
US5760218A (en) | 1993-03-26 | 1998-06-02 | Gist-Brocades N.V. | Diamine salts of clavulanic acid |
US5470481A (en) | 1993-10-13 | 1995-11-28 | Modell Environmental Corporation | Method and apparatus for recovering wash water from pulp and paper mill effluent |
WO1995011295A1 (en) | 1993-10-22 | 1995-04-27 | Gist-Brocades N.V. | An improved process to recover an aqueous fermentation broth |
GB9401969D0 (en) | 1994-02-02 | 1994-03-30 | Smithkline Beecham Plc | Process |
AT400846B (de) | 1994-02-25 | 1996-03-25 | Fermic S A De C V | Verfahren zur gewinnung und reinigung von alkalimetallsalzen der clavulansäure |
SI9400107A (en) * | 1994-03-02 | 1995-10-31 | Lek Tovarna Farmacevtskih | New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804. |
JPH0873227A (ja) | 1994-06-30 | 1996-03-19 | Olympus Optical Co Ltd | ガラス体の製造方法及びゲルの浸漬装置 |
US5650101A (en) | 1994-07-25 | 1997-07-22 | University Of South Florida | Lock and key micelles |
JP3617091B2 (ja) | 1994-11-30 | 2005-02-02 | 味の素株式会社 | 塩基性アミノ酸の精製方法 |
GB9426261D0 (en) | 1994-12-24 | 1995-02-22 | Spurcourt Ltd | Clavulanic acid salts |
ATE211143T1 (de) | 1995-02-25 | 2002-01-15 | Spurcourt Ltd | Clavulansäure salz |
KR100200242B1 (ko) | 1995-05-16 | 1999-06-15 | 김충환 | 클라불란산염의 제조 방법 |
GB9515809D0 (en) | 1995-08-02 | 1995-10-04 | Smithkline Beecham Plc | Process |
AT403375B (de) * | 1995-11-15 | 1998-01-26 | Biochemie Gmbh | Verfahren zur fällung von alkalisalzen der clavulansäure |
ES2101658B1 (es) | 1995-11-23 | 1998-03-01 | Antibioticos Sa | Nuevo procedimiento de produccion de acido clavulanico y sus sales. |
US5837365A (en) | 1996-04-08 | 1998-11-17 | The Penn State Research Foundation | Hydrophilic polypropylene membranes |
-
1994
- 1994-03-02 SI SI9400107A patent/SI9400107A/sl not_active IP Right Cessation
-
1995
- 1995-02-23 EP EP95909194A patent/EP0748387B1/en not_active Expired - Lifetime
- 1995-02-23 HU HU9602351A patent/HUT74944A/hu unknown
- 1995-02-23 US US08/632,402 patent/US5780274A/en not_active Expired - Fee Related
- 1995-02-23 KR KR1019960704806A patent/KR100293172B1/ko not_active IP Right Cessation
- 1995-02-23 RU RU96121357/13A patent/RU2206613C2/ru not_active IP Right Cessation
- 1995-02-23 RO RO96-01735A patent/RO118760B1/ro unknown
- 1995-02-23 SK SK1120-96A patent/SK279780B6/sk unknown
- 1995-02-23 CZ CZ962557A patent/CZ284117B6/cs not_active IP Right Cessation
- 1995-02-23 JP JP7522554A patent/JP2948661B2/ja not_active Expired - Fee Related
- 1995-02-23 PL PL95316085A patent/PL180520B1/pl not_active IP Right Cessation
- 1995-02-23 CA CA002184619A patent/CA2184619A1/en not_active Abandoned
- 1995-02-23 NZ NZ279958A patent/NZ279958A/en unknown
- 1995-02-23 WO PCT/SI1995/000002 patent/WO1995023870A1/en active IP Right Grant
- 1995-02-23 DE DE69500925T patent/DE69500925T2/de not_active Expired - Fee Related
- 1995-02-23 CN CN95191927A patent/CN1055694C/zh not_active Expired - Fee Related
- 1995-02-23 ES ES95909194T patent/ES2108572T3/es not_active Expired - Lifetime
- 1995-02-23 AT AT95909194T patent/ATE159549T1/de not_active IP Right Cessation
- 1995-02-23 AU AU17241/95A patent/AU694176B2/en not_active Ceased
- 1995-02-23 DK DK95909194.3T patent/DK0748387T3/da active
- 1995-03-01 ZA ZA951689A patent/ZA951689B/xx unknown
-
1996
- 1996-08-30 NO NO19963628A patent/NO318374B1/no unknown
- 1996-09-02 FI FI963408A patent/FI963408A/fi not_active IP Right Cessation
- 1996-09-02 BG BG100816A patent/BG62213B1/bg unknown
-
1998
- 1998-01-16 GR GR980400112T patent/GR3025942T3/el unknown
- 1998-07-10 US US09/113,790 patent/US5985625A/en not_active Expired - Fee Related
-
1999
- 1999-10-08 US US09/415,483 patent/US6207428B1/en not_active Expired - Fee Related
-
2001
- 2001-01-03 US US09/754,231 patent/US6566106B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2108572T3 (es) | Procedimiento para el aislamiento de acido clavulanico y de sales farmaceuticamente aceptables de este a partir del caldo de fermentacion de streptomyces sp p 6621 ferm p 2804. | |
BR9407907A (pt) | Processo para produzir uma substância alvo usando um microorganismo | |
EP0326151A3 (en) | Improved controlled release formulation | |
MX9708627A (es) | Oxazolidinonas de diazinilo y carbazinilo espirociclicas y biciclicas. | |
ES2010143A6 (es) | Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp. | |
GR930100090A (el) | Μέ?οδος για την παραγωγή αλάτων κλαβουλανικού οξέος. | |
EP0770684A3 (en) | Method for producing L-lactic acid with high optical purity using bacillus strains | |
AU629966B2 (en) | A microorganism for selective production of specific component of avermectin and a method for selective production thereof | |
BR9507521A (pt) | Formulação farmacêutica método para o tratemento de infecções bacterianas em seres humanos e animais uso de uma formulação e processo para sua preparação | |
AU6829796A (en) | Isolation of clavulanic acid from fermentation broth by ultrafiltration. | |
TW344743B (en) | Therapeutic nucleosides | |
AR013876A1 (es) | Un procedimiento para la produccion de acido clavulanico y sales farmaceuticamente aceptables del mismo | |
HU901427D0 (en) | Process for the preparation of ws7622 a, b, c and d | |
AU640241B2 (en) | Ws7622a mono- or di-sulfate, process for preparation thereof and use thereof | |
ES2130392T3 (es) | Procedimiento para la preparacion de acido clavulanico. | |
ES535512A0 (es) | Un procedimiento para producir el antibiotico sb 22484 o una de sus sales farmaceuticamente aceptables | |
NO930675L (no) | Anvendelse av et vandig naeringsmedium for formering av homofermentative melkesyrebakterier under usterile betingelser for tilsetning som sileringsmiddel til gjaeret for | |
PE33790A1 (es) | Procedimiento para producir acido l-glutamico | |
CA2393518A1 (en) | Amycomycin, a process for its production and its use as a pharmaceutical | |
CA2062667A1 (en) | Microbiological process for the production of 6-hydroxynicotinic acid | |
EP0390099A3 (de) | Polare Cephalosporinderivate und Verfahren zu ihrer Herstellung | |
AU5340196A (en) | Preparation of clavulanate salts | |
FR2248826A2 (en) | Antibiotic salinomycin - produced by cultivating Streptomyces albus and extracting the medium and mycelium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 748387 Country of ref document: ES |